AzTrials
AzTrials

ResuscitationDRIVE NetworkNCT06803498

Delivery Room Intervention and Evaluation Network

An observational study of Resuscitation and Infant, Newborn, run by American Academy of Pediatrics at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The American Academy of Pediatrics (AAP) convened the multi-center Delivery Room Intervention and Evaluation (DRIVE) Network to establish essential infrastructure to collect, coordinate, and analyze core demographic, resuscitative, and outcome data for an inclusive and diverse population of infants who receive… Read more about this study

Who is it for?
Ages 0 days to 1 day
Conditions the study is for
Resuscitation, Infant, Newborn
What is being tested?
Receipt of significant resuscitation intervention at birth
Type of treatment
Surgery or procedure
How many people
3,000,000 participants
Where
1 siteUnited States
Study dates
1 Jan 2022to 1 Jan 2042
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 days to 1 day
  • All sexes
  • No healthy volunteers
  • Child

Study population: All inborn infants who receive significant intervention (CPAP, PPV, intubation, or CPR) at birth in a DRIVE member hospital are included in the DRIVE Database. In addition, summary data is also collected on monthly delivery volume at all sites (stratified by gestational age) to allow for more precise incidence estimates of resuscitative interventions.

Who may be able to join

  • Inborn infant in receipt of a significant resuscitation intervention (CPAP, PPV, intubation, or CPR) at birth

Who cannot join

  • Not live born

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Beth Goins contact

630-626-6289

bgoins@aap.org

Jessica Weglarz, MBA contact

630-626-6037

jweglarz@aap.org

United States1 site, 1 recruiting
  • American Academy of Pediatrics

    Itasca, Illinois, 60143

    Beth Goins, (630) 626-6289, bgoins@aap.org

    Beena Kamath-Rayne, MD MPH FAAP

    Recruiting

Other trials in United States

About this study

Official title: Delivery Room Intervention and Evaluation (DRIVE) Network

The American Academy of Pediatrics (AAP) convened the multi-center Delivery Room Intervention and Evaluation (DRIVE) Network to establish essential infrastructure to collect, coordinate, and analyze core demographic, resuscitative, and outcome data for an inclusive and diverse population of infants who receive delivery room resuscitation at participating centers. The DRIVE Network consists of delivery hospitals across the United States, covering a range of geographic, urban/rural, racial/ethnic diversity across the country. Together, DRIVE seeks to compare practice-level delivery system characteristics, identify best practices, evaluate outcomes from various interventions, and promote professional development through dissemination via the wide reach of the Neonatal Resuscitation Program.

Read the detailed description

Basic neonatal resuscitation, which includes drying, warmth, stimulation, suctioning of the baby's nose/mouth as needed, and PPV, comprise the essential skills to which 95% of babies will respond and breathe, yet more data are collected about advanced resuscitative measures that occur in only 3-5% of deliveries. Existing neonatal networks and registries focus on high-risk and premature infants and are not all-inclusive of newborn babies and the basic neonatal resuscitation interventions which save the most lives, but about which little data have been collected in a standardized way. Studying quality of care at birth is also important as it is well known that there is variation between centers, as well as long-standing disparities in infant mortality in the United States.

The objective of this project is to establish essential infrastructure to collect and coordinate core demographic, resuscitative, and outcome variables in an inclusive and diverse population of infants at participating centers. The overarching goal is to relay data back to individual centers, benchmarking their own results against the entire network. Individual centers can employ quality improvement techniques to target professional development activities and improve resuscitation practices. AAP would also use these data to continually improve the educational framework around NRP. Additionally, external investigators could also submit proposals to query the network database on important research questions involving neonatal resuscitation.

Being tested
Receipt of significant resuscitation intervention at birth
Keywords
Continuous Positive Airway Pressure, Intermittent Positive Pressure Ventilation, Intubation, Intratracheal, Cardiopulmonary Resuscitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Receipt of significant resuscitation intervention at birthProcedure or surgery

    Receipt of CPAP, PPV, intubation, or CPR at birth in a hospital delivery room

Study groups in NCT06803498
Study groupRoleWhat they receive
DRIVE Network CohortAll infants who receive significant resuscitation intervention (CPAP, PPV, intubation, or CPR) at birth in a DRIVE Network member hospital.
Receives: Procedure: Receipt of significant resuscitation intervention at birth

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient disposition

    The disposition of the patient after resuscitation including newborn nursery, neonatal ICU including a special care nursery or transitional nursery, palliative care, or transfer to other hospital

    Measured: Immediately after the resuscitation intervention

Secondary outcomes (1)
  1. In-hospital mortality

    Whether the patient died following resuscitation

    Measured: Within 30 days after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2025
  2. Study start1 Jan 2022
  3. Primary completion1 Jan 2042 (estimated)
  4. Study completion1 Jan 2042 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
3,000,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06803498
Sponsor's protocol ID
21 FO 01
Acronym
DRIVE Network
Status last verified
Jan 2025
First submitted
27 Jan 2025
Last updated
31 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: For investigators interested in using DRIVE data for observational research, research proposals will be accepted, reviewed, and approved by the DRIVE Steering Committee. Once appropriate regulatory and data use agreements are in place, fully de-identified analytic datasets will be shared for approved protocols. Additionally, at least one DRIVE Steering Committee member will work with the study investigators as a liaison to support the investigators.

Questions about this trial

What is this clinical trial studying?

An observational study of Resuscitation and Infant, Newborn, run by American Academy of Pediatrics at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 31 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Beth Goins (630-626-6289, bgoins@aap.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient disposition (time frame: Immediately after the resuscitation intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in